Trials (Dec 2019)
Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
Abstract
Following publication of the original article [1], we have been notified that end note would need to be adjusted.